Siemens Healthineers reported net margins of 18.1% in the most recent quarter, up from 16.9% a year earlier. Over the past four quarters, the company has grown its revenue by an average of 7.3% year-over-year. Siemens Healthineers' focus on portfolio optimization and operational excellence initiatives appears to be paying off, with the company exhibiting steady improvements in both profitability and top-line growth. The company's ROIC has averaged 14.2% over the last four quarters, indicating efficient capital allocation and strong competitive positioning. Siemens Healthineers' leading market share in key product segments, such as diagnostic imaging and laboratory diagnostics, provides a solid foundation for sustained margin expansion. The company's diversified portfolio and global footprint further strengthen its competitive advantages. Given Siemens Healthineers' track record of operational excellence, ongoing portfolio optimization, and favorable industry tailwinds, I expect the company to continue expanding its net margins over the next 12-18 months, potentially reaching the 20% range.